You are here

  • Home
  • Archive
  • Volume 49, Issue 4
  • The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery

Article info

Article menu

Download PDFPDF

Gastro-oesphageal reflux and dyspepsia
The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery
Free

Authors

  • H E Myrvold aTrondheim University Hospital, Norway, bDepartment of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden, cUniversity Hospital, Kuopio, Finland, dOdense Hospital, Odense, Denmark, eHaukeland Hospital, Bergen, Norway, fErsta Hospital, Stockholm, Sweden, gAstraZeneca R&D, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • L Lundell aTrondheim University Hospital, Norway, bDepartment of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden, cUniversity Hospital, Kuopio, Finland, dOdense Hospital, Odense, Denmark, eHaukeland Hospital, Bergen, Norway, fErsta Hospital, Stockholm, Sweden, gAstraZeneca R&D, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • P Miettinen aTrondheim University Hospital, Norway, bDepartment of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden, cUniversity Hospital, Kuopio, Finland, dOdense Hospital, Odense, Denmark, eHaukeland Hospital, Bergen, Norway, fErsta Hospital, Stockholm, Sweden, gAstraZeneca R&D, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • S A Pedersen aTrondheim University Hospital, Norway, bDepartment of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden, cUniversity Hospital, Kuopio, Finland, dOdense Hospital, Odense, Denmark, eHaukeland Hospital, Bergen, Norway, fErsta Hospital, Stockholm, Sweden, gAstraZeneca R&D, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • B Liedman aTrondheim University Hospital, Norway, bDepartment of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden, cUniversity Hospital, Kuopio, Finland, dOdense Hospital, Odense, Denmark, eHaukeland Hospital, Bergen, Norway, fErsta Hospital, Stockholm, Sweden, gAstraZeneca R&D, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • J Hatlebakk aTrondheim University Hospital, Norway, bDepartment of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden, cUniversity Hospital, Kuopio, Finland, dOdense Hospital, Odense, Denmark, eHaukeland Hospital, Bergen, Norway, fErsta Hospital, Stockholm, Sweden, gAstraZeneca R&D, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • R Julkunen aTrondheim University Hospital, Norway, bDepartment of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden, cUniversity Hospital, Kuopio, Finland, dOdense Hospital, Odense, Denmark, eHaukeland Hospital, Bergen, Norway, fErsta Hospital, Stockholm, Sweden, gAstraZeneca R&D, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • K Levander aTrondheim University Hospital, Norway, bDepartment of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden, cUniversity Hospital, Kuopio, Finland, dOdense Hospital, Odense, Denmark, eHaukeland Hospital, Bergen, Norway, fErsta Hospital, Stockholm, Sweden, gAstraZeneca R&D, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • M Lamm aTrondheim University Hospital, Norway, bDepartment of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden, cUniversity Hospital, Kuopio, Finland, dOdense Hospital, Odense, Denmark, eHaukeland Hospital, Bergen, Norway, fErsta Hospital, Stockholm, Sweden, gAstraZeneca R&D, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • C Mattson aTrondheim University Hospital, Norway, bDepartment of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden, cUniversity Hospital, Kuopio, Finland, dOdense Hospital, Odense, Denmark, eHaukeland Hospital, Bergen, Norway, fErsta Hospital, Stockholm, Sweden, gAstraZeneca R&D, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • J Carlsson aTrondheim University Hospital, Norway, bDepartment of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden, cUniversity Hospital, Kuopio, Finland, dOdense Hospital, Odense, Denmark, eHaukeland Hospital, Bergen, Norway, fErsta Hospital, Stockholm, Sweden, gAstraZeneca R&D, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • N O Ståhlhammar aTrondheim University Hospital, Norway, bDepartment of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden, cUniversity Hospital, Kuopio, Finland, dOdense Hospital, Odense, Denmark, eHaukeland Hospital, Bergen, Norway, fErsta Hospital, Stockholm, Sweden, gAstraZeneca R&D, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • aTrondheim University Hospital, Norway, bDepartment of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden, cUniversity Hospital, Kuopio, Finland, dOdense Hospital, Odense, Denmark, eHaukeland Hospital, Bergen, Norway, fErsta Hospital, Stockholm, Sweden, gAstraZeneca R&D, Mölndal, Sweden Google scholar articles
  1. Professor H E Myrvold, Department of Surgery, Regionsykehuset in Trondheim, N-7006 Trondheim, Norway. helge.myrvold{at}medisin.ntnu.no
View Full Text

Citation

Myrvold HE, Lundell L, Miettinen P, et al
The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery
Gut 2001;49:488-494.

Publication history

  • Accepted January 8, 2001
  • First published October 1, 2001.
Online issue publication 
October 01, 2001

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

British Society of Gastroenterology